Herbal Technological Prospects of Morus nigra L.: A Systematic Patent Analysis Review
Recent Patents on Biotechnology · 2024-09 · 18 (3) · 241-256
DOI: 10.2174/1872208317666230821102411 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Recent Patents on Biotechnology, 2024-09. Verfasst von Larissa Pereira Alves und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Drug Technology, Department of Pharmaceutical Sciences, Federal University of Pernambuco. Av. Prof.Artur de Sá - Cidade Universitária, …. Hauptthemen laut MEDLINE: Morus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
Background
Morus nigra L. is a plant with significant potential for drug development due to the presence of numerous bioactive compounds in its various parts.
Objectives
This article aims to compile the technological perspectives of Morus nigra L. towards drug development and therapeutic indications based on registered patents in databases.
Methods
The study analyzed patents published within the last five years, focusing on products derived from different parts of the Morus nigra L. plant. Patent databases such as the European Patent Office (EPO), the United States Patent and Trademark Office (USPTO), the World Intellectual Property Organization (WIPO), and the National Institute of Industrial Property Databases (INPI) were examined.
Results
A total of 45 patents were categorized by country of origin, type of applicant, extraction method, and therapeutic indications. China had the highest number of patent filings (43.48%), and private companies were the primary technology patent holders (38.64%). Noteworthy extraction methods included ultrasound-assisted extraction, decoction, infusion, and maceration. The most utilized plant parts were leaves (44.44%), followed by fruits (35.56%), root bark (15.56%), and stems (4.44%). The main therapeutic indications identified were the treatment of hyperglycemia and dyslipidemia (43.33%), along with digestive problems, cosmetics, nutrition, and cleaning applications.
Conclusion
The study of patents covers discoveries and advancements often absent in scientific articles, making a review focused on this advanced information crucial for expanding existing scientific knowledge. Even if some therapies have been explored previously, patents can reveal innovative approaches and fresh perspectives that contribute to sustained scientific progress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Drug Technology, Department of Pharmaceutical Sciences, Federal University of Pernambuco. Av. Prof.Artur de Sá - Cidade Universitária, Recife, Pernambuco, Brazil.
- Drug, Medicine and Food Analytical Center, College of Pharmaceutical Sciences, Federal University of Vale do São Francisco, Av. José de Sá Maniçoba, Petrolina, Pernambuco, Brazil.
ORCID-Profile: Larissa Pereira Alves, Widson Michael Dos Santos, Myla Lôbo de Souza, Larissa Araújo Rolim, Pedro José Rolim-Neto
Zitieren
APA
Alves, L. P., Dos Santos, W. M., de Souza, M. L., Rolim, L. A., & Rolim-Neto, P. J. (2024). Herbal Technological Prospects of Morus nigra L.: A Systematic Patent Analysis Review. Recent Patents on Biotechnology, 18(3), 241-256. https://doi.org/10.2174/1872208317666230821102411
Vancouver
Alves LP, Dos Santos WM, de Souza ML, Rolim LA, Rolim-Neto PJ. Herbal Technological Prospects of Morus nigra L.: A Systematic Patent Analysis Review. Recent Patents on Biotechnology. 2024;18(3):241-256. doi:10.2174/1872208317666230821102411
BibTeX
@article{Alves2024,
author = {Alves, Larissa Pereira and Dos Santos, Widson Michael and de Souza, Myla Lôbo and Rolim, Larissa Araújo and Rolim-Neto, Pedro José},
title = {Herbal Technological Prospects of Morus nigra L.: A Systematic Patent Analysis Review},
journal = {Recent Patents on Biotechnology},
year = {2024},
volume = {18},
number = {3},
pages = {241--256},
doi = {10.2174/1872208317666230821102411}
}
EUVIMED